Form 4: Shattuck Labs Executive Granted Stock Options

Stephen Stout, General Counsel at Shattuck Labs, was granted stock options for 177,000 shares of common stock.

Summary

• Stephen Stout, General Counsel, Corporate Secretary, and Chief Ethics and Compliance Officer at Shattuck Labs, was granted stock options to purchase 177,000 shares of the company's common stock.
• The options have an exercise price of $1.18 per share.
• The options vest over a period of four years, with one quarter vesting on January 28, 2026, and the remaining three quarters vesting in equal monthly installments through January 28, 2029.
• The vesting is contingent upon Mr. Stout's continued service to the company.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no indications of negative sentiment.

Positives

• The granting of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Risks

• The value of the options is dependent on the future performance of Shattuck Labs' stock price.
• If Mr. Stout leaves the company before the options fully vest, he may forfeit some or all of the options.

Future Outlook

The stock options will vest over the next four years, subject to the executive's continued employment.

Management Comments

• Stephen Stout signed the document as General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer.

Industry Context

Granting stock options is a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in publicly traded companies, particularly in the biotech sector.
• Vesting schedules, such as the one described, are typical to ensure long-term alignment of interests between executives and shareholders.
• The specific terms of the grant, such as the exercise price and vesting period, are generally comparable to those offered by similar companies.

Stakeholder Impact

• Shareholders may view this as a positive sign of management's commitment to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, executive compensation, Shattuck Labs, vesting, Stephen Stout, equity